Estimated 5-year number needed to treat to prevent cardiovascular death or heart failure hospitalization with angiotensin receptor-neprilysin inhibition vs standard therapy for patients with heart failure with reduced ejection fraction: an analysis of data from the PARADIGM-HF Trial - Srivastava, P K; Claggett, B L; Solomon, S D (JAMA Cardiol, 2018)